Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesThe Hydration Pharmaceuticals Company Ltd

The Hydration Pharmaceuticals Company Ltd

Consumer Defensive Food Distribution
PortfolioPortfolio WatchlistWatchlist
Company price
0.002 AUD 0.00(0%)
Last update at 2026-11-04T23:00:00Z
Market Cap
1.08M

Momentum Score

…

The Hydration Pharmaceuticals Company Limited, together with its subsidiaries, markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, Canada, and the United States. It sells its products under the Hydralyte brand through retail stores and online. The company was founded in 2001 and is based in Melbourne, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.01
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on The Hydration Pharmaceuticals Company Ltd, an ASX-listed entity, is limited and available disclosures do not clearly document its products, clinical stage, or commercial operations. If the company is developing hydration-related pharmaceutical products, long-term growth would depend on successful R&D and regulatory approvals, effective commercialization partnerships, and access to distribution channels, which may benefit investors if material milestones are achieved.
Material risks include limited disclosure and transparency, the clinical and regulatory uncertainty typical of pharmaceutical development, and funding and liquidity risk on a small-cap exchange.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
2.15M
Revenue Per Share
0.01
Gross Profit TTM
1.03M
Debt / Equity
-10.87
ROE
-147.39%
Net Debt
-1.12M
ROCE
-229.32%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -2.85M -5.67M -8.10M -10.61M -8.97M
Net income -2.96M 2.67M -8.10M -10.61M -8.97M
Selling general administrative - 3.05M 6.29M 6.17M 4.49M
Selling and marketing expenses - 2.77M 6.85M 9.23M 4.83M
Gross profit -0.03M 1.62M 5.39M 4.70M 2.58M
Reconciled depreciation - - - - 0.00M
Ebit - -8.11M -7.74M -10.70M -5.33M
Ebitda -3.26M -3.91M -7.46M -10.52M -5.32M
Depreciation and amortization - 4.20M 0.28M - 0.00M
Operating income -3.26M -4.20M -6.87M -10.52M -5.33M
Other operating expenses 5.81M 7.40M 17.78M 19.80M 12.66M
Interest expense 0.00M 1.76M 0.64M 0.09M 3.64M
Tax provision - 0.00M 0.00M 0.00M 0.00M
Interest income - - - 0.00M 0.00M
Net interest income - -1.76M -0.64M -0.09M -3.95M
Extraordinary items - 8.34M -0.87M - -
Income tax expense - -0.00M -0.36M - 5.05M
Total revenue 2.56M 3.20M 10.04M 9.10M 5.92M
Total operating expenses 3.23M 5.82M 8.77M 15.40M 9.32M
Cost of revenue 2.59M 1.58M 4.65M 4.40M 3.34M
Total other income expense net 0.41M -1.48M -0.36M 0.19M 1.41M
Net income from continuing ops - -5.67M -8.10M -10.61M -12.35M
Net income applicable to common shares - 2.67M -8.10M -10.61M -8.95M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 2.19M 5.00M 6.69M 10.39M 15.31M
Other current assets 0.12M 0.34M 0.71M 1.01M 1.80M
Total liab 0.77M 2.25M 7.05M 6.41M 2.08M
Total stockholder equity 1.42M 2.74M -0.36M 3.98M 13.23M
Other current liab 0.63M 1.96M 2.07M 2.22M 1.49M
Common stock 40.51M 39.67M 39.33M 36.61M 36.45M
Capital stock - - - 36.61M 50.22M
Retained earnings -43.30M -40.41M -43.08M -34.98M -24.38M
Other liab - - - 0.02M 0.02M
Other assets - - - 0.00M -
Cash 1.12M 3.22M 1.84M 4.69M 10.67M
Total current liabilities 0.77M 2.23M 3.13M 2.68M 2.06M
Net debt -1.12M -3.22M 2.05M -0.98M -10.67M
Short term debt - - - 0.00M 0.00M
Short long term debt total - - 3.89M 3.71M -
Other stockholder equity - - 0.00M 2.34M -0.05M
Property plant equipment - - - - 0.00M
Total current assets 2.19M 5.00M 6.69M 10.39M 15.31M
Net tangible assets - - - 3.98M 13.23M
Net receivables 0.08M 0.34M 1.74M 1.31M 1.04M
Long term debt - - - 3.71M -
Inventory 0.87M 1.10M 2.39M 3.39M 1.79M
Accounts payable 0.15M 0.28M 1.06M 0.45M 0.57M
Accumulated other comprehensive income 4.21M 3.48M 3.39M 2.34M 1.21M
Non current assets total - - - 0.00M 0.00M
Long term debt total - - - 3.71M 0.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 9.44M - - -
Change to liabilities - - - 0.00M -0.13M
Total cashflows from investing activities - 9.44M - - 0.00M
Net borrowings - -6.50M - 4.08M 4.08M
Total cash from financing activities 0.83M -3.63M 2.72M 4.08M 17.03M
Change to operating activities - - - 0.67M -1.40M
Net income -2.85M 2.67M -8.10M -10.61M -12.35M
Change in cash -2.35M 1.38M -2.85M -5.98M 9.03M
Begin period cash flow 3.47M 1.84M 4.69M 10.67M 1.64M
End period cash flow 1.12M 3.22M 1.84M 4.69M 10.67M
Total cash from operating activities -3.78M -3.02M -5.73M -9.75M -8.08M
Issuance of capital stock - - 2.96M - 16.60M
Depreciation - - - - 0.00M
Other cashflows from investing activities - 9.44M - - 0.00M
Change to inventory 0.23M 0.86M 0.85M -1.72M -0.21M
Change to account receivables 0.27M 1.40M -0.44M - -0.24M
Sale purchase of stock - -0.02M -0.24M - 12.03M
Other cashflows from financing activities - -0.02M -0.25M - 4.99M
Change to netincome - - - 0.86M 2.53M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital -0.89M 2.49M 0.41M - -8.08M
Stock based compensation - - 1.03M - -
Other non cash items -0.04M -8.18M 0.93M - -
Free cash flow -3.78M -3.02M -5.73M -9.75M -11.14M

Peer Comparison*

Sector: Consumer Defensive Industry: Food Distribution

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
HPC
The Hydration Pharmaceuticals Company Ltd		 -
-%		 0.00 - - 0.50 1.15 0.14 -0.93
MTS
Metcash Ltd		 0.01
0.30%		 3.34 13.32 13.18 0.21 2.08 0.31 7.55

Profile*

The Hydration Pharmaceuticals Company Ltd

The Hydration Pharmaceuticals Company Limited, together with its subsidiaries, markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, Canada, and the United States. It sells its products under the Hydralyte brand through retail stores and online. The company was founded in 2001 and is based in Melbourne, Australia.

6 Palmer Parade, Cremorne, Melbourne, VIC, Australia, 3121

61 3 9614 2444

https://hydralyte.com

Name Title Year Born
Mr. Oliver Baker Chief Exec. Officer NA
Mr. Chris Kavanaugh Chief Financial Officer NA
Ms. Carlie Hodges Company Sec. NA
Mr. Oliver Baker Chief Executive Officer NA
Ms. Victoria Nadalin Company Secretary NA
Mr. Oliver Baker Chief Executive Officer NA
Ms. Victoria Nadalin Company Secretary NA
Ms. Victoria Alexis Nadalin Company Secretary NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…